Skip to content

Minimally Invasive versus Conventional Interval Debulking Surgery for Epithelial Ovarian Carcinoma

Minimally Invasive versus Conventional Interval Debulking Surgery for Epithelial Ovarian Carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202505733159189
Enrollment
43
Registered
2025-05-06
Start date
2021-07-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Interventions

Laparoscopic interval debulking for advanced ovarian carcinoma
Open debulking

Sponsors

Myself
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: • Histologically proven advanced epithelial ovarian cancer (International Federation of Gynecology and Obstetrics - FIGO stage III–IV). • Unresectable disease at primary assessment confirmed either by laparoscopy, laparotomy, or combined CT scan evaluation and cytology. • Cases that respond to neoadjuvant chemotherapy with complete or partial response to treatment according to the Response Evaluation Criteria of Solid Tumours (RECIST). • Patients with good performance status < 2

Exclusion criteria

Exclusion criteria: • Early/resectable epithelial ovarian cancer cases. • Borderline or non-epithelial ovarian tumours. • Progressive disease after neoadjuvant chemotherapy. • Patients with bad performance status > 2

Design outcomes

Primary

MeasureTime frame
Oncologic outcomes (short-term, between 6-24 months) have been recorded and compared between the two groups regarding: 1.Disease free and overall survival of patients. 2.Time of recurrence (if any). 3.Site of recurrence (if any).

Secondary

MeasureTime frame
Surgical outcomes have been recorded and compared between the two groups regarding: 1. Completeness of surgery 2. Integrity of tumour specimen 3. Lymph Node harvest 4. Peritoneal biopsy harvest 5. Operative time and complications 6. Amount of blood loss and transfusion 7. Duration of hospital stay 8. Postoperative complications

Countries

Egypt

Contacts

Public ContactAhmed Eid

Surgical Oncology Specialist

ahmedeid_43@hotmail.com+201007744981

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026